CoChat

Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial

Open access
Molenaar, Nina M., Brouwer, Marlies E., Bockting, Claudi L. H., Bonsel, Gouke J., van der Veere, Christine N., Torij, Hanneke W., Hoogendijk, Witte J. G., Duvekot, Johannes J., Burger, Huibert, Lambregtse-van den Berg, Mijke P. · 2016 · BMC Psychiatry
Cited by 27

The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Approximately 6.2 % of women in the USA and 3.7 % of women in the UK, use Selective Serotonin Reuptake Inhibitors (SSRIs) during their pregnancies because of depression and/or anxiety. In the Netherlands, this prevalence is around 2 %. Nonetheless, SSRI use during pregnancy is still controversial. On the one hand SSRIs may be toxic to the intrauterine developing child, while on the other hand relapse or recurrence of depression during pregnancy poses risks for both mother and child. Among patients and professionals there is an urgent need for evidence from randomized studies to make rational decisions regarding continuation or tapering of SSRIs during pregnancy. At present, no such studies exist. METHODS/DESIGN: 'Stop or Go' is a pragmatic multicentre randomized non-inferiority trial among 200 pregnant women with a gestational age of less than 16 weeks who use SSRIs without clinically relevant depressive symptoms. Women allocated to the intervention group will receive preventive cognitive therapy with gradual, guided discontinuation of SSRIs under medical management (STOP). Women in the control group will continue the use of SSRIs (GO). Primary outcome will be the (cumulative) incidence of relapse or recurrence of maternal depressive disorder (as assessed by the Structured Clinical Interview for DSM disorders) during pregnancy and up to three months postpartum. Secondary outcomes will be child outcome (neonatal outcomes and psychomotor and behavioural outcomes up to 24 months postpartum), and health-care costs. Total study duration for participants will be therefore be 30 months. We specified a non-inferiority margin of 15 % difference in relapse risk. DISCUSSION: This study is the first to investigate the effect of guided tapering of SSRIs with preventive cognitive therapy from early pregnancy onwards as compared to continuation of SSRIs during pregnancy. We will study the effects on both mother and child with a pragmatic approach. Additionally, the study examines cost effectiveness. If non-inferiority of preventive cognitive therapy with guided tapering of SSRIs compared to intended continuation of SSRIs is demonstrated for the primary outcome, this may be the preferential strategy during pregnancy. TRIAL REGISTRATION: Netherlands Trial Register (NTR): NTR4694 ; registration date: 16-jul-2014.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1186/s12888-016-0752-6

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 32 references

Research works printed but not linked: 35

  1. Quispel C, Schneider TAJ, Bonsel GJ, Lambregtse-van den Berg MP. An innovative screen-and-advice model for psychopathology and psychosocial problems among urban pregnant women: an exploratory study. J Psychosom Obstet Gynecol. 2012;33(1):7–14. · DOI · Paper page
  2. Gynaecologie NVvOe. Richtlijn: SSRI-gebruik in de zwangerschap en tijdens de lactatie. 2012.
  3. Yonkers KA, Gotman N, Smith MV, Forray A, Belanger K, Brunetto WL, et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology. 2011;22(6):848–54. doi: 10.1097/EDE.0b013e3182306847 . · DOI · Paper page
  4. De Vera MA, Berard A. Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension. Br J Clin Pharmacol. 2012;74(2):362–9. doi: 10.1111/j.1365-2125.2012.04196.x . · DOI · Paper page
  5. Grigoriadis S, VonderPorten EH, Mamisashvili L, Roerecke M, Rehm J, Dennis CL, et al. Antidepressant exposure during pregnancy and congenital malformations: Is there an association? A systematic review and meta-analysis of the best evidence. J Clin Psychiatry. 2013;74(4):e293–308. doi: 10.4088/JCP.12r07966 . · DOI · Paper page
  6. Furu K, Kieler H, Haglund B, Engeland A, Selmer R, Stephansson O, et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design. BMJ. 2015;350:h1798. doi: 10.1136/bmj.h1798 . · DOI · Paper page
  7. Kieler H, Artama M, Engeland A, Ericsson O, Furu K, Gissler M et al. Selective serotonin reuptake inhibitors during pregnancy and risk of persistent pulmonary hypertension in the newborn: Population based cohort study from the five Nordic countries. BMJ (Online). 2012;344(7842). doi:10.1136/bmj.d8012 · DOI · Paper page
  8. Huybrechts KF, Bateman BT, Palmsten K, Desai RJ, Patorno E, Gopalakrishnan C, et al. Antidepressant use late in pregnancy and risk of persistent pulmonary hypertension of the newborn. JAMA. 2015;313(21):2142–51. doi: 10.1001/jama.2015.5605 . · DOI · Paper page
  9. Grigoriadis S, VonderPorten EH, Mamisashvili L, Eady A, Tomlinson G, Dennis CL, et al. The effect of prenatal antidepressant exposure on neonatal adaptation: a systematic review and meta-analysis. J Clin Psychiatry. 2013;74(4):e309–20. doi: 10.4088/JCP.12r07967 . · DOI · Paper page
  10. Bockting CL, Smid NH, Koeter MW, Spinhoven P, Beck AT, Schene AH. Enduring effects of preventive cognitive therapy in adults remitted from recurrent depression: a 10 year follow-up of a randomized controlled trial. J Affect Disord. 2015;185:188–94. doi: 10.1016/j.jad.2015.06.048 . · DOI
  11. Kuyken W, Hayes R, Barrett B, Byng R, Dalgleish T, Kessler D, et al. Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial. Lancet. 2015;386(9988):63–73. doi: 10.1016/S0140-6736(14)62222-4 . · DOI · Paper page
  12. Ververs T, van Dijk L, Yousofi S, Schobben F, Visser GH. Depression during pregnancy: views on antidepressant use and information sources of general practitioners and pharmacists. BMC Health Serv Res. 2009;9:119. doi: 10.1186/1472-6963-9-119 . · DOI
  13. Hampton T. Antidepressants and pregnancy: weighing risks and benefits no easy task. JAMA. 2006;295(14):1631–3. doi: 10.1001/jama.295.14.1631 . · DOI
  14. Excellence NIfHaC. Antenatal and postnatal mental health: clinical management and service guidance. 2014.
  15. Yonkers KA, Wisner KL, Stewart DE, Oberlander TF, Dell DL, Stotland N, et al. The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstet Gynecol. 2009;114(3):703–13. doi: 10.1097/AOG.0b013e3181ba0632 . · DOI · Paper page
  16. Levinson-Castiel R, Merlob P, Linder N, Sirota L, Klinger G. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006;160(2):173–6. doi: 10.1001/archpedi.160.2.173 . · DOI · Paper page
  17. First MB, Spitzer RL, Gibbon M, Williams JB. Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Research Version, Patient Edition. Biometrics Research. New York: New York State Psychiatric Institute; 2002.
  18. Hamilton M. Rating depressive patients. J Clin Psychiatry. 1980;41(12 Pt 2):21–4.
  19. Bockting CL, Elgersma HJ, van Rijsbergen GD, de Jonge P, Ormel J, Buskens E, et al. Disrupting the rhythm of depression: design and protocol of a randomized controlled trial on preventing relapse using brief cognitive therapy with or without antidepressants. BMC Psychiatry. 2011;11:8. doi: 10.1186/1471-244X-11-8 . · DOI · Paper page
  20. Bockting CL, Kok GD, van der Kamp L, Smit F, van Valen E, Schoevers R, et al. Disrupting the rhythm of depression using mobile cognitive therapy for recurrent depression: randomized controlled trial design and protocol. BMC Psychiatry. 2011;11:12. doi: 10.1186/1471-244X-11-12 . · DOI · Paper page
  21. Dennis CL, Kingston D. A systematic review of telephone support for women during pregnancy and the early postpartum period. J Obstet Gynecol Neonatal Nurs. 2008;37(3):301–14. doi: 10.1111/j.1552-6909.2008.00235.x . · DOI
  22. Kingston D, Austin MP, Hegadoren K, McDonald S, Lasiuk G, McDonald S, et al. Study protocol for a randomized, controlled, superiority trial comparing the clinical and cost- effectiveness of integrated online mental health assessment-referral-care in pregnancy to usual prenatal care on prenatal and postnatal mental health and infant health and development: the Integrated Maternal Psychosocial Assessment to Care Trial (IMPACT). Trials. 2014;15:72. doi: 10.1186/1745-6215-15-72 . · DOI · Paper page
  23. Committee GEA. Australian clinical practice guidelines for depression and related disorders -- anxiety, bipolar disorder and puerperal psychosis -- in the perinatal period. A guideline for primary health care professionals. Melbourne: Beyondblue; 2011.
  24. Spielberger CD. State-Trait Anxiety Inventory: Bibliography. 2nd ed. Palo Alto: Consulting Psychologists Press; 1989.
  25. Marteau TM, Bekker H. The development of a six-item short-form of the state scale of the Spielberger State-Trait Anxiety Inventory (STAI). Br J Clin Psychol. 1992;31(Pt 3):301–6. · DOI · Paper page
  26. Bernstein DP, Stein JA, Newcomb MD, Walker E, Pogge D, Ahluvalia T, et al. Development and validation of a brief screening version of the childhood trauma questionnaire. Child Abuse Negl. 2003;27(2):169–90. · DOI · Paper page
  27. Weissman A. Dysfunctional Attitude Scale: A validation study. Unpublished doctoral dissertation. 1979. Available at: http://repository.upenn.edu/cgi/viewcontent.cgi?article=2994&context=edissertations · DOI
  28. Horne R. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1997;14(1):1–24. doi: 10.1080/08870449908407311 . · DOI · Paper page
  29. Quispel C, Bangma M, Kazemier BM, Steegers EAP, Hoogendijk WJG, Papatsonis DNM, et al. The role of depressive symptoms in the pathway of demographic and psychosocial risks to preterm birth and small for gestational age. Midwifery. 2014;30(8):919–25. · DOI · Paper page
  30. Rosenbaum JF, Fava M, Hoog SL, Ascroft RC, Krebs WB. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry. 1998;44(2):77–87. · DOI · Paper page
  31. Staufenbiel SM, Penninx BW, Spijker AT, Elzinga BM, van Rossum EF. Hair cortisol, stress exposure, and mental health in humans: a systematic review. Psychoneuroendocrinology. 2013;38(8):1220–35. doi: 10.1016/j.psyneuen.2012.11.015 . · DOI · Paper page
  32. Einspieler C, Prechtl HF. Prechtl’s assessment of general movements: a diagnostic tool for the functional assessment of the young nervous system. Ment Retard Dev Disabil Res Rev. 2005;11(1):61–7. doi: 10.1002/mrdd.20051 . · DOI · Paper page
  33. Zuk L. Fetal and infant spontaneous general movements as predictors of developmental disabilities. Dev Disabil Res Rev. 2011;17(2):93–101. doi: 10.1002/ddrr.1104 . · DOI
  34. Rescorla LA. Assessment of young children using the Achenbach System of Empirically Based Assessment (ASEBA). Ment Retard Dev Disabil Res Rev. 2005;11(3):226–37. doi: 10.1002/mrdd.20071 . · DOI · Paper page
  35. Yonkers KA, Gotman N, Smith MV, Forray A, Belanger K, Brunetto WL, et al. Does antidepressant use attenuate the risk of a major depressive episode in pregnancy? Epidemiology. 2011;22(6):848–54. · DOI · Paper page

Cited by

See all 27

Metadata

Authors
Molenaar, N. M., Brouwer, M. E., Bockting, C. L. H., Bonsel, G. J., van der Veere, C. N., Torij, H. W., Hoogendijk, W. J. G., Duvekot, J. J., Burger, H., & Lambregtse-van den Berg, M. P.
Venue
BMC Psychiatry
Published
2016-03-18
Volume
16
Issue
1
Pages
72-72
ISSN
1471-244X (ISSN-L)
OpenAlex
W2300554243
Cited by
27
References
32
FWCI
3.93
Type
journal article
Language
en
Open access
gold
Funders
ZonMw (836021011)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial. https://app.cochat.ai/papers/10.1186/s12888-016-0752-6
The paper
Molenaar, N. M., Brouwer, M. E., Bockting, C. L. H., Bonsel, G. J., van der Veere, C. N., Torij, H. W., Hoogendijk, W. J. G., Duvekot, J. J., Burger, H., & Lambregtse-van den Berg, M. P. (2016). Stop or go? Preventive cognitive therapy with guided tapering of antidepressants during pregnancy: study protocol of a pragmatic multicentre non-inferiority randomized controlled trial. BMC Psychiatry. https://doi.org/10.1186/s12888-016-0752-6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.